Volume 13, Number 3 (Apr 2022)

Editorial

JADPRO Live Virtual 2021: New Paths to Patient Care

This special issue of JADPRO includes summaries of educational sessions presented at JADPRO Live Virtual 2021.

April 21, 2022

Meeting Report

Positive Practice Changes After the COVID-19 Pandemic: From the Advanced Practice Provider Perspective

At the opening session of JADPRO Live Virtual 2021, panelists shared creative responses to the COVID-19 pandemic and considered strategies to effectively respond to crises that may impact cancer patients and practices in the future.

April 21, 2022

Meeting Report

Pull Up a Seat: Engaging Patients as Empowered Partners in Health Equity Transformation

At the JADPRO Live Virtual 2021 keynote interview, Maimah Karmo, CEO and Founder of the Tigerlily Foundation, spoke with Amy Pierre, MSN, ANP-BC, on her breast cancer experience and drive to establish an organization that educates, advoc...

April 21, 2022

Meeting Report

Identifying the Leader in You

The leadership journey is often a long and winding road, with speed bumps and unexpected turns. During this session of JADPRO Live Virtual, presenters discussed the leadership qualities that they have found integral, including emotional ...

April 21, 2022

Meeting Report

Thriving, Not Just Surviving: Recognizing Burnout and Simple Tips to Start Feeling Better

Burnout has been prevalent since before COVID-19 and continues to affect a large portion of the health-care workforce. At JADPRO Live Virtual 2021, Margaret Leddy, PA-C, MMSc, defined burnout in the setting of the oncology/hematology adv...

April 21, 2022

Meeting Report

A Call to Action: The Role of the Oncology AP in Equitable Cancer Care

The COVID-19 pandemic has only further brought to light how racism, bias, and lack of equity can result in social injustice, morbidity, and mortality. A panel of four advanced practitioners convened at JADPRO Live Virtual 2021 to examine...

April 21, 2022

Meeting Report

The Advanced Practice Role in Clinical Trials: Past, Present, and Future

At JADPRO Live Virtual 2021, Colleen Lewis, MSN, ANP-BC, AOCNP®, discussed the trajectory of the advanced practitioner role in clinical research, including the historical experience, potential barriers to practice, and future possibiliti...

April 21, 2022

Meeting Report

Race, Social Determinants of Health, and Cancer: How Can APs Address and Improve Patient Outcomes?

The data show that racial and ethnic minority groups throughout the United States experience higher rates of illness and death across a wide range of health conditions when compared to their White counterparts. This session at JADPRO Liv...

April 21, 2022

Meeting Report

Multidisciplinary Tumor Boards and Guiding Patient Care: The AP Role

The history of multidisciplinary tumor boards extends to more than 50 years ago. At JADPRO Live Virtual 2021, presenters discussed the evidence-based impact of tumor boards on patient outcomes and patient-centered care, reviewed benefits...

April 21, 2022

Meeting Report

Clinically Relevant Drug Interactions in the Cancer Setting

Along with the fast pace of oncology drug approvals is the heightened opportunity for drug-drug, drug-food, and drug-herbal interactions. Attendees at the JADPRO Live Virtual 2021 conference learned about the pharmacodynamic and pharmaco...

April 21, 2022

Meeting Report

Cardio-Oncology Considerations in Oncologic Treatment Decisions

At JADPRO Live Virtual 2021, presenter Anecita P. Fadol, PhD, FNP-BC, FAANP, FAAN, emphasized the critical role advanced practitioners play in the identification, monitoring, and management of the cardiac complications of cancer therapy....

April 21, 2022

Meeting Report

Mental Health in the Oncology Setting: General Considerations and Treatment Tips

Patients with comorbid mental health and substance use disorders are at greater risk for mortality and have higher cancer care costs. At JADPRO Live Virtual 2021, Lisa W. Goldstone, MS, PharmD, BCPS, BCPP, talked through general consider...

April 21, 2022

Meeting Report

An AP Perspective on Infusion Reactions in the Era of Immunotherapy

As cancer care advances, creative uses for immunotherapy continue to be developed, but it is also important to be cognizant of the risk for infusion reactions. At JADPRO Live Virtual 2021, Carrie Peterson, DNP, RN, AGNP-c, reviewed the d...

April 21, 2022

Meeting Report

Direct Oral Anticoagulants and Cancer Thrombosis: What APs Need to Know

Patients with cancer are at high risk for developing cancer-associated blood clots. Mailey L. Wilks, DNP, APRN, NP-C, led a session at JADPRO Live Virtual 2021 on the risk of venous thromboembolism in patients with cancer, available anti...

April 21, 2022

Meeting Report

Survivorship Care Challenges: Navigating Changing Concerns

Advanced practitioners are often in charge of planning and implementing care for cancer survivors, as noted by Carrie Tompkins Stricker, PhD, RN, ANP-BC, during JADPRO Live Virtual 2021. During a session at the conference, Dr. Stricker r...

April 21, 2022

Meeting Report

Herbal Medicine: Friend or Foe?

Many cancer patients report the use of supplements and herbal medicines but may not always disclose their use to their health-care team. Along with potential interactions, these therapies may also affect outcomes of treatment. During JAD...

April 21, 2022

Meeting Report

Oncology Urgent Care Clinics: Understanding Utilization and Best Practices

An oncology urgent care clinic can improve patient satisfaction, reduce emergency room visits, and lower health-care costs for patients and facilities. At a session taking place at JADPRO Live Virtual 2021, presenters on the frontlines o...

April 21, 2022

Meeting Report

The Critical Role of Nutrition and Exercise: Optimization in the Patient With Cancer

Undergoing surgery is one of the greatest physical and emotional challenges a patient can face, and doing so without preparation can lead to increased complications and mortality. At JADPRO Live Virtual 2021, Paul Wischmeyer, MD, EDIC, F...

April 21, 2022

Meeting Report

2020–2021 Drug Updates in Solid Tumors

During JADPRO Live Virtual 2021, Christine Cambareri, PharmD, BCPS, BCOP, CSP, briefed advanced practitioners on drugs and biologics that were approved for the treatment of solid tumors from late 2020 to late 2021, including their advers...

April 21, 2022

Meeting Report

2020–2021 Drug Updates in Hematologic Malignancies

During JADPRO Live Virtual 2021, Kirollos Hanna, PharmD, BCPS, BCOP, discussed the label indications of drugs and biologics in hematologic malignancies approved from late 2020 to late 2021, including mechanisms of action and various safe...

April 21, 2022

Meeting Report

2020–2021 Drug Updates: Investigational Therapeutics in the Pipeline

During JADPRO Live Virtual 2021, Donald C. Moore, PharmD, BCPS, BCOP, DPLA, discussed investigational therapeutic agents in the drug development pipeline. Dr. Moore highlighted agents that represent either a new drug class, a novel mecha...

April 21, 2022

Meeting Report

Biomarker Jeopardy

In the popular Biomarker Jeopardy session, Sandra E. Kurtin, PhD, ANP-C, AOCN®, Alyssa Henglefelt, PharmD, BCOP, and Haleigh Mistry, MS, PA-C, paired biomarkers with tumor types for which their expression is most commonly used to determi...

April 21, 2022

Meeting Report

Immunotherapy for the Treatment of Triple-Negative Breast Cancer

At JADPRO Live Virtual 2021, Sara M. Tolaney, MD, MPH, and Lindsay Shaw, ANP-BC, AOCNP®, presented on recent clinical trial data for approved immune checkpoint inhibitors and antibody-drug conjugates, and their implications in the curren...

April 21, 2022

Meeting Report

Lung Cancer Biomarker Speak: Teach Me the Language

A vital role of the advanced practitioner is to analyze biomarker testing reports and explain to patients how the results may impact their treatment. At JADPRO Live Virtual 2021, presenters reviewed the importance of molecular testing in...

April 21, 2022

Meeting Report

Multidisciplinary Management of Resectable Early-Stage Non-Small Cell Lung Cancer

During JADPRO Live Virtual 2021, three advanced practitioners—in surgery, radiation oncology, and medical oncology—discussed their collaboration in the management of resectable early-stage non–small cell lung cancer. The presenters discu...

April 26, 2022

Meeting Report

Multidisciplinary Management of Pancreatic Cancer

At JADPRO Live Virtual 2021, presenters reviewed the epidemiology of pancreatic cancer, treatment options for patients with different stages of pancreatic cancer, and the most common symptoms and complications related to pancreatic cance...

April 21, 2022

Meeting Report

Updates in the Management of Renal Cell Carcinoma

At JADPRO Live Virtual 2021, advanced practitioner experts reviewed clinical updates in the treatment of renal cell carcinoma, key patient counseling and monitoring considerations, and best practices to manage adverse events associated w...

April 21, 2022

Meeting Report

Updates in Cholangiocarcinoma

Cholangiocarcinoma is a spectrum of invasive adenocarcinomas that arise in the intrahepatic, perihilar, or distal biliary tree, and is classified by location. During JADPRO Live Virtual 2021, Kristen O’Hagan, MSN, RN, ANP-BC, AOCNP®, dis...

April 21, 2022

Meeting Report

Molecular Testing in Hematologic Malignancies

Molecular testing technologies have been increasingly integrated into clinical research and are essential tools in the care of patients with hematologic malignancies. During this session at JADPRO Live Virtual 2021, Laura J. Zitella, MS,...

April 21, 2022

Meeting Report

New Frontiers: The Role of CAR T-Cell Therapy in Multiple Myeloma

Multiple myeloma remains the second most common hematologic malignancy, and relapse rates are high, with refractory disease common with each relapse. Chimeric antigen receptor (CAR)–modified T cells are a promising new treatment, and at ...

April 21, 2022

Meeting Report

Role of the Advanced Practitioner in the Management of Oral Chemotherapy for Adults With AML

Recent advances have resulted in an expansion of treatment options for AML, especially targeted therapies and low-intensity regimens. At JADPRO Live Virtual 2021, presenters reviewed novel and targeted oral chemotherapy for adults with A...

April 21, 2022

Meeting Report

The 4 T’s of ITP: Tailoring Therapies to Treat Thrombocytopenia

Immune thrombocytopenia (ITP) is an acquired autoimmune bleeding disorder characterized by the destruction of platelets and megakaryocytes. Its management has changed significantly in recent years, and at JADPRO Live Virtual 2021, David ...

April 21, 2022

Meeting Report

Updates in the Diffuse Large B-Cell Lymphoma Treatment Landscape

During JADPRO Live Virtual 2021, presenters discussed updates in the treatment of diffuse large B-cell lymphoma (DLBCL), including novel agents and chimeric antigen receptor (CAR) T-cell therapy, and how the treatment and management of p...

April 21, 2022

Editorial

Letter to the Editor

We read with interest the April 2022 JADPRO meeting report article, “Molecular Testing in Hematologic Malignancies”, as presented by Laura Zitella, MS, RN, ACNP-BC, AOCN®. We were pleased that Ms. Zitella chose to share information about...